Biomea Fusion Inc.
Clinical trials sponsored by Biomea Fusion Inc., explained in plain language.
-
New obesity drug BMF-650 enters early human safety testing
Disease control OngoingThis early-stage study tests a new drug called BMF-650 in 80 healthy adults who are overweight or obese. The main goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo, and researchers monitor side effects and vital …
Phase: PHASE1 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated May 26, 2026 06:37 UTC
-
New pill targets leukemia in early trial
Disease control OngoingThis early-phase study tests a new daily pill called BMF-500 in adults with acute myeloid leukemia (AML) that has come back or not responded to treatment. The drug targets a specific genetic change (FLT3 mutation) found in some leukemias. The main goals are to check safety, find …
Phase: PHASE1 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated May 26, 2026 06:23 UTC